4 Midcap High Operating Margin and High ROE Stocks to Watch for Future Multibagger Potential: MCX, Mazagon Dock, Ajanta Pharma and Hindustan Copper

High operating margin and high ROE stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. MCX, Mazagon Dock, Ajanta Pharma and Hindustan Copper meet that test, with market caps from Rs 39,822 crore to Rs 82,566 crore and MCX offering the highest return on equity at 46.75%. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and an operating margin of at least 20 per cent and a return on equity of at least 20 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.

This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and an operating margin of at least 20 per cent and a return on equity of at least 20 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening high operating margin and high ROE stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 30 October 2026 and are drawn from NSE and BSE data and company filings.

Click Here – Get Free Investment Predictions

What Are High Operating Margin and High ROE Stocks and Why Do They Attract Multibagger Interest?

High operating margin and high ROE stocks are shares of mid sized companies that keep at least twenty paise of operating profit from every rupee of sales and also earn a return on equity of twenty per cent or more, a mix that marks a strong and efficient business. The four here cover commodity exchange services, shipbuilding, pharmaceuticals and copper mining.

A high margin shows pricing power and cost control, and a high return on equity shows that shareholder money is put to good use, so the two together point to a business with a real edge. Within high operating margin and high ROE stocks, the four companies show rising profit. For high operating margin and high ROE stocks, both FY26 and the latest quarter showed growth. Whichever way you read high operating margin and high ROE stocks, the common thread is rising profit backed by complete financial data. With high operating margin and high ROE stocks, comparing valuation, growth and balance sheet strength together works better than relying on one number. Every company in the table below passed a rising-profit check, and the figures for high operating margin and high ROE stocks are complete. Read each company’s latest results and exchange filings before acting on high operating margin and high ROE stocks.

High Operating Margin and High ROE Stocks at a Glance: Price, Market Cap, PE and ROE

Prices are closing prices as of 30 October 2026. Mazagon Dock has the lowest PE of the group at 26.37, while MCX posts the highest return on equity at 46.75%.

Stock	CMP (Rs)	Market Cap (Rs Cr)	PE	Industry PE	ROE	Debt to Equity	52-Week Range (Rs)
Multi Commodity Exchange of India	3,188.80	82,566	53.55	42.17	46.75%	0.00	1,762.10 to 3,481.40
Mazagon Dock Shipbuilders	1,705.30	75,248	26.37	48.92	26.48%	0.05	1,705.30 to 2,881.80
Ajanta Pharma	3,508.80	44,167	38.92	36.35	23.33%	0.06	2,380.20 to 3,796.00
Hindustan Copper	400.85	39,822	35.05	12.27	27.48%	0.03	308.50 to 760.05

MCX: 74.55% Profit CAGR Since FY22

MCX is India’s leading commodity derivatives exchange, where gold, silver, crude oil, natural gas and base metals contracts are traded. It reported FY26 revenue of Rs 2,429.05 crore, up 100.94% year on year, and net profit of Rs 1,331.55 crore, up 137.76%. Net profit has compounded at 74.55% a year since FY22, while revenue has grown 53.87% a year. Operating margin was 76.83% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.

In the June 2026 quarter, revenue rose 85.25% to Rs 751.79 crore and net profit grew 103.47% to Rs 413.44 crore. The share price has gained 720.06% over five years and 69.44% over the past year. Foreign investors raised their holding from 21.69% in June 2025 to 29.84% in June 2026. The stock trades at a PE of 53.55 against an industry PE of 42.17, with a return on equity of 46.75%.

Mazagon Dock: 44.01% Profit CAGR Since FY22

Mazagon Dock Shipbuilders builds warships and submarines for the Indian Navy and is a key defence shipyard. It reported FY26 revenue of Rs 14,145.71 crore, up 12.77% year on year, and net profit of Rs 2,421.88 crore, up 6.35%. Net profit has compounded at 44.01% a year since FY22, while revenue has grown 23.18% a year. Operating margin was 26.20% in FY26. The debt-to-equity ratio is 0.05, which keeps interest costs low.

The stock trades at a PE of 26.37 against an industry PE of 48.92, below the sector average, with a return on equity of 26.48%. In the June 2026 quarter, revenue rose 10.40% to Rs 3,255.88 crore and net profit grew 22.12% to Rs 512.04 crore. The share price has gained 1461.53% over five years. Promoters hold 81.22%, which keeps ownership stable.

Ajanta Pharma: Return on Equity of 23.33%

Ajanta Pharma sells branded generics in ophthalmology, dermatology, cardiology and pain management in India, Africa and Asia. It reported FY26 revenue of Rs 5,624.93 crore, up 18.60% year on year, and net profit of Rs 1,056 crore, up 14.73%. Net profit has compounded at 10.33% a year since FY22, while revenue has grown 12.94% a year. Operating margin was 28.74% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.

In the June 2026 quarter, revenue rose 27.68% to Rs 1,696.86 crore and net profit grew 30.89% to Rs 334.22 crore. The share price has gained 125.31% over five years and 35.42% over the past year. Domestic institutions raised their holding from 17.90% in September 2025 to 21.94% in September 2026. The stock trades at a PE of 38.92 against an industry PE of 36.35, with a return on equity of 23.33%.

Hindustan Copper: 25.25% Profit CAGR Since FY22

Hindustan Copper is a government-owned company that mines copper ore and produces refined copper in India. It reported FY26 revenue of Rs 3,149.67 crore, up 46.62% year on year, and net profit of Rs 920.66 crore, up 96.97%. Net profit has compounded at 25.25% a year since FY22, while revenue has grown 13.89% a year. Operating margin was 46.74% in FY26. The debt-to-equity ratio is 0.03, which keeps interest costs low.

The stock trades at a PE of 35.05 against an industry PE of 12.27, with a return on equity of 27.48%. In the June 2026 quarter, revenue rose 81.07% to Rs 953.60 crore and net profit grew 162.59% to Rs 352.61 crore. The share price has gained 205.23% over five years and 33.08% over the past year. Foreign investors raised their holding from 3.71% in June 2025 to 5.96% in June 2026.

High Operating Margin and High ROE Stocks: Financial Comparison on Growth and Margins

The table compares scale and growth across these high operating margin and high ROE stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.

Stock	Revenue (Rs Cr)	Net Profit (Rs Cr)	Revenue Growth (YoY)	4-Year Revenue CAGR	4-Year Net Profit CAGR	Operating Margin (Latest Quarter)
MCX	2,429.05	1,331.55	100.94%	53.87%	74.55%	77.49%
Mazagon Dock	14,145.71	2,421.88	12.77%	23.18%	44.01%	25.82%
Ajanta Pharma	5,624.93	1,056	18.60%	12.94%	10.33%	30.41%
Hindustan Copper	3,149.67	920.66	46.62%	13.89%	25.25%	56.02%

Check the Univest Screener for live data on these high operating margin and high ROE stocks

Institutional Holding in MCX, Mazagon Dock, Ajanta Pharma and Hindustan Copper

Institutional holding shows who is backing these high operating margin and high ROE stocks alongside the promoter. The table uses the latest reported quarter for each. MCX has the deepest institutional backing, with FII and DII together holding 80.65% as of June 2026. Domestic institutions increased their holding over the past year in Ajanta Pharma (from 17.90% to 21.94%).

Stock	Promoter	FII	DII	Public	Quarter
MCX	Nil	29.84%	50.81%	19.34%	June 2026
Mazagon Dock	81.22%	1.72%	5.01%	12.04%	June 2026
Ajanta Pharma	63.47%	7.63%	21.94%	6.96%	September 2026
Hindustan Copper	66.14%	5.96%	4.84%	23.06%	June 2026

Risks to Weigh in High Operating Margin and High ROE Stocks

Being careful with high operating margin and high ROE stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:

• Past growth may not repeat.
• Share prices can move sharply in either direction.
• Valuation: Hindustan Copper trades at a PE of 35.05 against an industry PE of 12.27, so earnings need to keep growing to support the price.
• Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.

How to Choose Between High Operating Margin and High ROE Stocks

Picking from high operating margin and high ROE stocks comes down to four checks, applied in order.

1. Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
2. Compare each PE with the industry PE (12.27 to 48.92) and ask whether the growth rate justifies any gap.
3. Track net profit growth, the operating margin and the return on equity in every quarterly result.
4. Stagger entries across quarters and review institutional holding every reporting season.

Download the Univest iOS App or Univest Android App to track MCX, Mazagon Dock, Ajanta Pharma and Hindustan Copper live prices.

Conclusion

Among high operating margin and high ROE stocks, MCX stands out for the highest return on equity at 46.75%, Mazagon Dock for the biggest five-year price gain at 1461.53%, Ajanta Pharma for a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.06 and Hindustan Copper for the strongest latest-quarter profit growth at 162.59%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing high operating margin and high ROE stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.

Frequently Asked Questions on High Operating Margin and High ROE Stocks to Watch

Which are the best high operating margin and high ROE stocks to watch for multibagger potential?

Ans. MCX, Mazagon Dock, Ajanta Pharma and Hindustan Copper are the 4 names this list highlights, with market caps of Rs 82,566 crore, Rs 75,248 crore, Rs 44,167 crore and Rs 39,822 crore respectively. MCX is notable for the highest return on equity at 46.75%. Mazagon Dock stands out for the biggest five-year price gain at 1461.53%. Ajanta Pharma offers a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.06. Hindustan Copper brings the strongest latest-quarter profit growth at 162.59%. These are watchlist names for high operating margin and high ROE stocks, not recommendations, so match each one to your own risk profile and time horizon.

Is MCX a good stock for long-term investors?

Ans. MCX has a return on equity of 46.75%, a PE of 53.55 against an industry PE of 42.17 and a market cap of Rs 82,566 crore. Net profit has compounded at 74.55% a year since FY22, and FY26 revenue rose 100.94% while June 2026 quarter net profit grew 103.47%. Long-term returns in high operating margin and high ROE stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.

Can Mazagon Dock become a multibagger from here?

Ans. Mazagon Dock has already gained 1461.53% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in high operating margin and high ROE stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 44.01% a year since FY22, and FY26 revenue rose 12.77%. At a PE of 26.37 against an industry PE of 48.92, valuation should be checked against that growth before investing.

What is the market cap of MCX, Mazagon Dock, Ajanta Pharma and Hindustan Copper?

Ans. As of 30 October 2026, MCX has a market cap of Rs 82,566 crore, Mazagon Dock has a market cap of Rs 75,248 crore, Ajanta Pharma has a market cap of Rs 44,167 crore and Hindustan Copper has a market cap of Rs 39,822 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on high operating margin and high ROE stocks.

What are the risks of investing in high operating margin and high ROE stocks?

Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Hindustan Copper trades at a PE of 35.05 against an industry PE of 12.27, so earnings growth needs to hold up.

Why is Hindustan Copper trading at a PE of 35.05?

Ans. Hindustan Copper’s PE of 35.05 compares with an industry PE of 12.27. The market is paying a premium for a return on equity of 27.48%, profit growth of 25.25% a year since FY22 and latest-quarter profit growth of 162.59%, which also means the stock is more sensitive if growth slows. Investors in high operating margin and high ROE stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.

How much do institutions hold in MCX, Mazagon Dock, Ajanta Pharma and Hindustan Copper?

Ans. As of the latest reported quarter, FII and DII together hold 80.65% of MCX (29.84% and 50.81%), 6.73% of Mazagon Dock (1.72% and 5.01%), 29.57% of Ajanta Pharma (7.63% and 21.94%) and 10.80% of Hindustan Copper (5.96% and 4.84%). Rising institutional holding is a useful signal in high operating margin and high ROE stocks, though it should be read with earnings trends rather than on its own.